David Dolphin has worked throughout his career on compounds call porphyrins (pronounced POUR-fur-ins). Porphyrins are pigments found in both animal and plant life. They are involved in the formation of many important substances in the body including hemoglobin, which carries oxygen in the blood.
Dr. Dolphin used his ability to synthesize these compounds to create a porphyrin to absorb a specific wavelength of light. When injected into tissue and exposed to laser light, this compound was found to be effective in killing skin cancer cells.
In the course of clinical trials, it was discovered that the compound, called Visudyne today, also stopped the growth of new blood vessels, thus closing down the nutrient source for the cancer cells.
This unintended effect proved effective in treating age-related macular degeneration (AMD). The “wet” version of this disease results in spontaneous growth of new blood vessels in the retina of the eye, which kills off the normal cells, thereby causing blindness. By using Visudyne and laser light to stop the growth of new blood vessels, vision is preserved.
The clinical trials of Visudyne to treat AMD — the most common cause of vision loss in people over age 50 in the Western world — were successful and the treatment has now been approved for use in 70 countries. The causes of AMD are unknown, but thanks to David Dolphin’s work in creating Visudyne, millions of people worldwide will be able to keep their sight.